Assignee
APEIRON BIOLOGICS AG
AT·8 granted patents·9 pending applications·27 citations·filing 2012–2023
Top patents by PatentIndex Score
17 records- 0190US10294305B2Method for treating a GD2 positive cancerAPEIRON BIOLOGICS AG·Filed 2014·Granted May 21, 2019·20 cites·21 claims
- 0289US9840566B2Preparations and methods for treating a GD2 positive cancerAPEIRON BIOLOGICS AG·Filed 2014·Granted Dec 12, 2017·7 cites·16 claims
- 0375US2023340148A1Method for treating a gd2 positive cancerAPEIRON BIOLOGICS AG·Filed 2022·Application pending·0 cites
- 0474US2024158530A1Preparations and methods for treating a gd2 positive cancerAPEIRON BIOLOGICS AG·Filed 2023·Application pending·0 cites
- 0569US11492412B2Preparations and methods for treating a GD2 positive cancerAPEIRON BIOLOGICS AG·Filed 2021·Granted Nov 8, 2022·0 cites·26 claims
- 0669US10995147B2Preparations and methods for treating a GD2 positive cancerAPEIRON BIOLOGICS AG·Filed 2020·Granted May 4, 2021·0 cites·1 claims
- 0765US11597775B2Preparations and methods for treating a GD2 positive cancerAPEIRON BIOLOGICS AG·Filed 2017·Granted Mar 7, 2023·0 cites·14 claims
- 0865US11447565B2Method for treating a GD2 positive cancerAPEIRON BIOLOGICS AG·Filed 2017·Granted Sep 20, 2022·0 cites·22 claims
- 0959US2020055953A1Method for Treating a GD2 Positive CancerAPEIRON BIOLOGICS AG·Filed 2019·Application pending·0 cites
- 1058US10716833B2Method for producing ACE2 polypeptideAPEIRON BIOLOGICS AG·Filed 2017·Granted Jul 21, 2020·0 cites·6 claims
- 1158US2024093173A1Methods for treatment of virusAPEIRON BIOLOGICS AG·Filed 2021·Application pending·0 cites
- 1255US2025360211A1Population of transfected immune cells and method for their productionAPEIRON BIOLOGICS AG·Filed 2023·Application pending·0 cites
- 1353US2014099297A1Ace2 polypeptideAPEIRON BIOLOGICS AG·Filed 2013·Application pending·0 cites
- 1447US2018117126A1Treatment of inflammatory illnesses with ace2APEIRON BIOLOGICS AG·Filed 2017·Application pending·0 cites
- 1538US2014322308A1Compositions for Preventing or Treating Adverse Reactions of EGFR InhibitionAPEIRON BIOLOGICS AG·Filed 2012·Application pending·0 cites
- 1635US10472341B2Bicyclic tetrahydrothiazepine derivatives useful for the treatment of neoplastic and/or infectious diseasesAPEIRON BIOLOGICS AG·Filed 2016·Granted Nov 12, 2019·0 cites·30 claims
- 1734US2015313931A1Sirna against cbl-b and optionally il-2 and il-12 for use in the treatment of cancerAPEIRON BIOLOGICS AG·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when APEIRON BIOLOGICS AG files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →